The spheroid/organoid in the glass incubator is so tiny that Mohammad I. AlWahsh can barely see it with his eye.
Novel NMR Technique Using 3D Models Simplifies the Quest for Cancer Drugs It has been five years since Mohammad Ibrahim AlWahsh came to Germany as an exchange student. Back then, he was doing his Master’s in pharmaceutical science at Al Zaytoonah University of Jordan. Impressed by the quality of the research in Germany, he decided to stay for his doctorate. Since 2018, the 27-year-old has been working on methods of analytical toxicology to improve the treatment of a rare form of cancer in the thymus gland. With success – AlWahsh and his colleagues at ISAS and Heidelberg University recently succeeded in using their method to measure the live reaction to chemotherapeutic agents in 3D models for the first time. Moreover, they were able to highlight possible therapeutic options for patients with thymoma and thymic carcinoma. Thymoma and thymic carcinoma are both tumours in the thymus gland, a central organ of the lymphatic system and thus of the immune defence system in humans. Both are so-called thymic epithelial tumours (TETs). According to information published by the American Society of Clinical Oncology (ASCO) in 2021, about
Disease mechanisms & Targets
23
